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Computational analyses have identified the widespread occurrence of antisense transcripts in the human and the mouse genome. However, the
structure and the origin of the majority of the antisense transcripts are unknown. The presence of antisense transcripts for 19 of 64 differentially
expressed genes during mouse spermatogenesis was demonstrated with orientation-specific RT-PCR. These antisense transcripts were derived
from a wide variety of origins, including processed sense transcripts, intronic and exonic sequences of a single gene or multiple genes, intergenic
sequences, and pseudogenes. They underwent normal and alternative splicing, 5′ capping, and 3′ polyadenylation, similar to the sense transcripts.
There were also antisense transcripts that were not capped and/or polyadenylated. The testicular levels of the sense transcripts were higher than
those of the antisense transcripts in all cases, while the relative expression in nontesticular tissues was variable. Thus antisense transcripts have
complex origins and structures and the sense and antisense transcripts can be regulated independently.
Published by Elsevier Inc.Keywords: Antisense transcription; Intron; Exon; Intergenic; Pseudogene; Mouse; Spermatogonia; Spermatocytes; SpermatidsAlthough antisense transcription has been known to occur
in prokaryotes for many years, the widespread occurrence of
antisense transcripts in humans and mice has only recently
been documented. Computational analyses estimated 8 to
20% of human and mouse genes form sense–antisense
transcript pairs [1–4]. A more recent study of 10 human
chromosomes indicated about 61% of surveyed loci have
antisense transcripts [5]. The significance of the majority of
antisense transcripts is currently unknown, though a number
of biological functions have been proposed [6]. A role for
antisense transcription in disease processes has also been
suggested [7–10]. Despite this apparent biological impor-
tance of the antisense transcripts, very little is known of the
mechanisms by which they are generated. Structural
information of antisense transcripts is also very limited.⁎ Corresponding author. Fax: +1 301 480 4700.
E-mail address: chanwy@mail.nih.gov (W.-Y. Chan).
0888-7543/$ - see front matter. Published by Elsevier Inc.
doi:10.1016/j.ygeno.2005.12.006Furthermore, the occurrence of antisense transcription in
specific biological processes has rarely been studied. A
number of biological events in spermatogenesis such as
genomic imprinting, translation repression, and stage-specific
alternative splicing [11] are frequently associated with
antisense transcripts. A systematic search for antisense
transcripts in spermatogenic cells has not been reported.
Recent profiling of expressed genes in mouse germ cells at
different stages of development, including type A spermato-
gonia, pachytene spermatocytes, and round spermatids, by
serial analysis of gene expression (SAGE) [12] offered a
unique opportunity to examine the occurrence of antisense
transcription during this critical process in development. This
study documents the occurrence of antisense transcripts in
these three types of germ cells. Characterization of antisense
transcripts cloned revealed the complex origins and structural
features of these RNA molecules. Expression studies showed
that the sense and the antisense transcripts can be regulated
independently.
Table 1
Genes with presence of antisense transcripts in testis confirmed by orientation-
specific RT-PCR using total RNA as template
Symbol Gene name SAGE tag No. in
Spga–Spcy–Sptd
(S/AS)
Mean Δ
cycle
No. ± SD
testicular
total RNA
Approximate
S/AS
Ch10 Heat shock 10-
kDa
protein 1
(chaperone 10)
106–2–2/
6–0–0
3.85 ± 0.35 14
Calm2 Calmodulin 2 110–304–40/
6–20–0
4.07 ± 0.44 17
Ppic Peptidylprolyl
isomerase C
14–1–0/7– 20–11 5.02 ± 0.75 32
Pdcl2 Phosducin-like 2 0–82–91/0–5–7 6.52 ± 0.22 92
Ubb Ubiquitin B 198–769–510/
7–59–21
7.35 ± 0.16 163
Sh3-
Stam
Associated
molecule with the
SH3 domain of
STAM
1–7–0/0–7–0 7.72 ± 1.00 211
Tsg1 Testis-specific
gene 1
0–310–419/
0–31–51
8.70 ± 0.15 416
Gk-rs2 Glucokinase
activity, related
sequence 2
0–54–41/0–6–5 9.00 ± 0.32 512
Uba52 Ubiquitin A-52
residue ribosomal
protein fusion
product 1
531–113–203/
20–4–13
9.20 ± 0.15 588
Tetc3 T-complex-
associated testis
expressed 3
4–471–360/
6–20–0
9.88 ± 1.09 942
Prm1 Proteamine 1 0–41–177/0–2–26 9.88 ± 0.20 942
Dnajb3 DnaJ (Hsp40)
homolog,
subfamily B,
member 3
0–63–84/0–4–12 10.50 ± 0.21 1448
Ppp1cc Protein
phosphatase 1,
catalytic subunit,
γ isoform
82–363–382/
5–18–6
10.70 ± 0.34 1663
Prm2 Protamine 2 0–103–147/0–1–9 12.50 ± 0.12 5792
Dbil5 Diazeparm
binding inhibitor-
like 5
2–64–119/0–1–4 14.50 ± 0.13 23,170
Ldh3C Lactate
dehydrogenase 3,
C chain, sperm
specific
0–282–243/0–4–2 16.10 ± 0.89 70,239
Adam5 A disintegrin and
metalloprotease
domain 5
3–54–92/0–12–4 16.81 ± 1.54 114,898
Sap17 Sperm
autoantigenic
protein 17
2–116–377/
1–21–30
17.47 ± 0.45 181,549
Fhl4 Four and a half
LIM domain 4
0–164–272/
2–19–27
19.54 ± 1.72 762,300
The germ cell SAGE tag numbers are from Ref. [12]. SAGE tag No. in Spga–
Spcy–Sptd, number of SAGE tags in type A spermatogonia, pachytene
spermatocytes, and round spermatids; S, sense; AS, antisense; Mean Δ cycle
No. ± SD, means of difference in QPCR cycle number between sense and
antisense transcripts and standard deviation of the means with testicular total
RNA as template; Approximate S/AS, approximate ratio of expression levels of
sense/antisense transcripts calculated from QPCR cycle numbers.
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Orientation-specific reverse transcription-polymerase chain
reaction (RT-PCR)
Sixty-four genes that had been confirmed to be differentially
expressed in mouse germ cells at different stages of spermato-
genesis by microarray [13] and/or quantitative real-time RT-
PCR (QPCR) and corroborated by SAGE [12] were selected for
this investigation. The list of the genes is shown in
Supplementary Table S1. Thirteen differential expression
patterns could be distinguished (results not shown). The most
common pattern of expression was 0 or very low in
spermatogonia and equally high in spermatocytes and sperma-
tids (18 genes). The second most common pattern of expression
was 0 or very low in spermatogonia, increased in spermato-
cytes, and peaked in spermatids (17 genes). The copy number of
the representative SAGE tag of the majority of the genes (52
genes) was either 0 (33 genes) or very low in spermatogonia. To
identify the antisense transcripts, SAGE tags matching the
UniGene cluster of the genes were identified and multiple
SAGE tags matching the same UniGene cluster were aligned
with all mRNAs deposited in that UniGene cluster. Orientation
of the transcript represented by the SAGE tag was determined in
reference to the known mRNA and confirmed by orientation-
specific RT-PCR [14].
Following alignment of the matching SAGE tags with
sequences in their respective UniGene clusters, 41 genes (64%)
were shown to have SAGE tags matching the antisense strand
(Supplementary Table S1). The presence of sense–antisense
overlapping transcript was confirmed for 19 genes with
orientation-specific RT-PCR using testicular total RNA as the
template (Table 1). The results of analysis of the products of
orientation-specific RT-PCR using polyacrylamide gel electro-
phoresis (PAGE) are shown in Supplementary Fig. S1. Among
the rest of the 41 genes, 10 genes were considered to be not
confirmed of having antisense transcripts because a band was
present in the no-primer control of the RT-PCR. The remaining
12 genes were not analyzed by orientation-specific RT-PCR
because the copy number of the antisense SAGE tags was
extremely low. Expression of the antisense transcript was
confirmed by cloning and sequencing of the amplicons of the
orientation-specific RT-PCR. Thus, 19 of 64 (∼30%) differen-
tially expressed genes had antisense transcripts.
Examination of the nucleotide sequence of the antisense
amplicons showed that they could be divided into three main
groups based on the comparison with their sense genes. Fig. 1
shows the three groups of antisense amplicons. In group 1 the
antisense amplicons were 100% complementary to the sense
transcripts. This group could be divided into two subgroups. In
subgroup 1A, the amplicon was contained in a single exon. This
subgroup included the antisense transcript of a disintegrin and
metalloprotease domain 5 (Adam5); diazepam-binding inhibi-
tor-like 5 (DbiL5); DnaJ (Hsp40) homolog, subfamily B,
member 3 (DnajB3); four and a half LIM domains 4 (Fhl4);
glucokinase activity-related sequence 2 (Gk-rs2); phosducin-
like 2 (Pdcl2); peptidylprolyl isomerase C (Ppic); γ isoform of
Fig. 1. Grouping of antisense amplicons based on their structure. For groups 1A, 1B, and 2, antisense amplicons are represented by yellow and brown bars and are
shown on the top. Sense gene sequences are represented by red and pink bars and are shown on the bottom. For group 3, pseudogene is represented by a striped bar. The
noncoding strand of the sense gene is represented by a white bar. Complementarity is represented by short black lines linking the antisense amplicon with the sense
sequence. Thick black lines represent introns.
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(Prm2); sperm autoantigenic protein 17 (Sap17); associated
molecule with the SH3 domain of STAM (Sh3-Stam); and
testis-specific gene 1 (Tsg1). Subgroup 1B antisense amplicons
were 100% complementary to the sense transcripts, which
comprised two (T-complex-associated testis expressed 3
(Tcte3)) or three (sperm-specific lactate dehydrogenase 3, C
chain (Ldh3c)) spliced exons. Similar to amplicons of group 1B,
the group 2 antisense amplicon consisted of more than one
exon. However, different from group 1B amplicons, only part of
the antisense amplicon was complementary to the exons in the
sense transcript. Part of the antisense amplicon was comple-
mentary to the intron between the two exons of the sense gene.
The antisense amplicon of protamine 1 (Prm1-ASF1 (GenBank
Accession No. DQ082992)) belonged to this group. Group 3
antisense amplicons were not complementary to the sense
transcripts. Instead, they were complementary to the pseudo-
genes. Four antisense amplicons, namely those of calmodulin 2
(Calm-2), heat shock 10-kDa protein 1 (chaperonin 10) (Ch10),
ubiquitin A-52 residue ribosomal protein fusion product 1
(Uba52), and ubiquitin B (Ubb), belonged to this group. The
antisense amplicons of these genes, namely, Calm2-ASF1
(GenBank Accession No. DQ082990), Ch10-ASF1 (GenBank
Accession No. DQ082993), Uba52-ASF1 (GenBank Accession
No. DQ082994), and Ubb-ASF1 (GenBank Accession No.
DQ082991), were 88–94% identical to their sense transcripts,
but were 99% identical to their pseudogenes on chromosomes
12, 2, 11, and 2, respectively (Figs. 2B to 2E).
Total complementarity of the antisense amplicons of the
genes in group 1B to the spliced exons of the sense genes
suggested that they were synthesized after the sense transcripts
were processed. Similar observations had been made with
antisense transcripts of cardiac troponin 1 [15], hemoglobin β
[16], and rat urocortin [17]. It had been postulated that these
antisense transcripts were transcribed from the sense mRNA in
the cytoplasm by RNA-dependent RNA polymerase activity
[4,15], a biological activity hypothesized but not yet demon-
strated in eukaryotic cells. Sequence of the antisense amplicon
of the gene in group 2 suggested that it was generated bysplicing of two exons in accordance with the AG/GT(C) rule
[18], implying a similar RNA processing mechanism in both
sense and antisense transcription. A number of antisense
transcripts had been reported to arise in a similar manner
previously [19–25]. Thus, the noncoding strand of a gene locus
could be transcribed and processed independently to produce a
mature transcript. Both functional genes and pseudogenes could
give rise to antisense transcripts as shown by the group 3
antisense amplicons. Pseudogene-derived antisense transcripts
are not unique to germ cells. The antisense transcript of neural
nitric oxide synthase (nNOS) was also reported to be transcribed
from a pseudogene [26]. Judging from the proportion of
antisense transcripts derived from pseudogenes and the number
of such genes identified in the mouse and human genome [27],
pseudogenes may be a rich source of antisense transcripts.
Molecular cloning and characterization of antisense
transcripts
T-complex-associated testis expressed 3
To understand further the nature of the antisense transcripts,
we cloned and characterized the antisense transcripts of one
member each of group 1B, group 2, and group 3. Cloning of the
antisense transcripts of Tcte3 of group 1B yielded 18 distinct
clones, which could be assigned to two groups based on the size
of the transcript. Fig. 3A shows a cartoon of the Tcte3 antisense
transcripts, A-Tcte3-a (GenBank Accession No. DQ072383)
and A-Tcte3-b (GenBank Accession No. DQ072384). The
presence of the longer antisense transcript, A-Tcte3-b, was
confirmed by amplifying the entire transcript using the most 5′
and 3′ primers in one RT-PCR. The nucleotide sequences of A-
Tcte3-a and A-Tcte3-b are shown in Fig. 3B. A-Tcte3-a was
identical to the first 532 nucleotides of A-Tcte3-b except for an
additional 18 A's. Blasting A-Tcte3-b against the mouse genome
revealed that the first 704 nucleotides of A-Tcte3-b were the
reverse complement of exon 4 (164 bp) of Tcte3 (NT_039641),
including 246 and 294 bp, respectively, on the 5′ and 3′ side of
this exon (Fig. 3B). However, the 50 nucleotides upstream of
the poly(A) tail could not be found in the Tcte3 gene. These 50
Fig. 2. Nucleotide sequence of group 2 and group 3 antisense amplicons.
Primers for amplification are represented by broken line with arrow. Notation of
the primers refers to the sense transcript. (A) Prm1-ASF1. The antisense
amplicon sequence is on the top. The complementary sense sequence is on the
bottom. Uppercase letters represent exon sequence and lowercase letters
represent intronic sequence. (B) Calm2-ASF1. The antisense amplicon of
calmodulin 2. (C) Ch10-ASF1, antisense amplicon of chaperonin 10. (D)
Uba52-ASF1, antisense amplicon of ubiquitin A-52 ribosomal protein fusion
product 1. (E) Ubb-ASF1, antisense amplicon of ubiquitin B.
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seven repeats in some clones and eight repeats in the others
interrupted by an AAAC sequence. The SAGE tag sequences
identified in the germ cell SAGE libraries were present in the
antisense transcripts. Computer-assisted translation of the
antisense transcripts revealed open reading frames (ORF) of
117 to 144 bp. The largest ORF encoded a putative
polypeptide of 48 amino acids with no recognizable protein
motif, indicating that the antisense transcript might serve as a
noncoding regulatory RNA [28]. Unlike the antisense
amplicon identified by orientation-specific RT-PCR, neither
of the Tcte3 antisense transcripts overlapped more than one
exon. The cloning approaches selected transcripts with a poly
(A) sequence at the 3′ end (3′ rapid amplification of cDNA
ends (RACE)) or a cap at the 5′ end (5′ RACE). Therefore the
results suggested there exist more than two species of
antisense transcripts of Tcte3, some of which were not
polyadenylated and capped, similar to that observed in a
number of noncoding regulatory RNAs [28].
Protamin 1 and 2
Three full-length antisense transcripts (A-Prm[1-2]-a
(GenBank Accession No. DQ072380), A-Prm[1-2]-b (Gen-
Bank Accession No. DQ072381), and A-Prm[1-2]-c (GenBank
Accession No. DQ072383)) of the sole member of group 2, i.e.,
Prm1, were cloned; upon analysis, these turned out to overlap
Prm1 as well as the neighboring Prm2. These transcripts were
alternative splice variants containing different numbers of
exons. The presence of these transcripts was confirmed by
single RT-PCRs using the most 3′ and 5′ primers. The structure
of the antisense transcripts is shown in Fig. 4A. The nucleotide
sequence of A-Prm[1-2] is shown in Fig. 4B. The shortest
antisense transcript was A-Prm[1-2]-a, which had 921 bp and a
poly(A) tail. It had four exons, with the first exon overlapping
the most 3′ 126 bp of Prm2 (BC049612), and exons 2 and 3
were the reverse complement of Prm1 (NM_013637). A-Prm[1-
2]-b was identical to A-Prm[1-2]-a with an additional exon
(exon 3) of 116 bp, which overlapped part of the intergenic
sequence between Prm1 and Prm2. It had a poly(A) tail. The
longest antisense transcript was A-Prm[1-2]-c, which was
identical to A-Prm[1-2]-b with an additional exon (exon 2) of
147 bp and a poly(A) tail. The 5′ end of exon 2 overlapped the
5′-most 112 bp of exon 1 of Prm2. Computer-assisted
translation of the three antisense transcripts identified
a similar ORF of 318 bp encoding a putative polypeptide
containing four casein kinase II phosphorylation sites and four
myristoylation sites as shown in Fig. 4B. A number of protein-
encoding antisense transcripts had been reported previously
[20,23,29,30]. Whether the Prm[1-2] antisense transcripts
encode any protein awaits validation.
The Prm[1-2] antisense transcripts contained multiple exons
whose splice variants followed the AG/GT(C) rule [18]. These
antisense exons overlapped with exonic, intronic, and intergenic
sequences of the sense genes. Similar to the sense transcripts,
the antisense transcripts underwent alternative splicing. This
phenomenon had also been demonstrated in other studies
[21,23,31,32]. Thus, processing of some antisense transcripts
Fig. 3. Antisense transcripts of T-complex testis expressed 3. (A) Cartoon of the Tcte3 antisense transcripts. The SAGE tags identifying these antisense transcripts are
shown in the boxes with the number of SAGE tags in each cell type shown as spermatogonia/spermatocytes/spermatids [12]. The area of complementary to the sense
exon is flanked by the dotted lines. The 3′ poly(A) tail and the 5′ cap site of the antisense transcripts are shown. For the sense gene, the boxes represent exons while the
thick line represents introns and flanking sequence of the gene. Empty boxes represent untranslated region and filled boxes represents translated sequence. The sizes of
the exons, introns, and intergenic regions are not to scale. (B) Nucleotide sequence of A-Tcte3-b.▵ indicates the end of sequence homology between A-Tcte3-a and A-
Tcte3-b. For A-Tcte3-a, there are 18 A's after that point. The polymorphic AAAAC stretch is marked with asterisks. The number of AAAAC is polymorphic, with 6 in
some clones and 7 in the others. The two SAGE tag sequences identified in germ cell SAGE libraries are underlined.⇒⇐ demarcate the boundaries of the sequence
that is reverse complementary to exon 4 of Tcte3.
685W.-Y. Chan et al. / Genomics 87 (2006) 681–692follows rules similar to those of the sense transcripts. It was
interesting to note that the Prm[1-2] antisense transcripts
spanned two neighboring genes. Thus, they might interact with
both sense transcripts. Examination of the SAGE tags in the
germ cell libraries indicated two antisense tags that overlapped
with the second exon of Prm2 [12]. Since SAGE tags are close
to the 3′ end of transcripts, this observation suggested the
presence of antisense transcripts that overlapped primarily with
the Prm2 gene.
Ubiquitin A-52 residue ribosomal protein fusion product 1
The antisense transcripts of Uba52 in group 3 were cloned.
5′ RACE yielded two groups of clones, neither of which were
derived from the functional Uba52 gene on chromosome
8 (Fig. 5A). They were derived from two putative pseudo-
genes, one on the tip of the short arm of chromosome 4
(NT_039258) and the other on the long arm of chromosome 9
(NT_039472). Both pseudogenes were 97–98% homologous
to Uba52 mRNA (BC014772) with no introns and a putative
ancestral poly(A) stretch with 24 and 17 A's, respectively. 3′
RACE using primers based on the 5′ RACE products
subsequently yielded three groups of antisense transcriptsderived from the pseudogene on chromosome 4 (A-Uba52-4a
(GenBank Accession No. DQ072385), A-Uba52-4b (GenBank
Accession No. DQ072386), and A-Uba52-4c (GenBank
Accession No. DQ072387)) and four groups of antisense
transcripts derived from the pseudogene on chromosome 9 (A-
Uba52-9a (GenBank Accession No. DQ072388), A-Uba52 -9b
(GenBank Accession No. DQ072389), A-Uba52-9c (GenBank
Accession No. DQ072390), and A-Uba52-9d (GenBank
Accession No. DQ072391)). The presence of these transcripts
was confirmed by successful RT-PCR with the most 5′ and
most 3′ primers. Fig. 5A shows the cartoon depicting the
intron–exon structure of the Uba52 antisense transcripts. The
nucleotide sequences of the antisense transcripts of Uba52 are
shown in Fig. 5B. It is interesting to notice that the short
amplicon generated by orientation-specific RT-PCR was
derived from another pseudogene of Uba52 on chromosome
11, indicating that only a portion of the antisense transcripts of
this gene were cloned in this exercise.
All the antisense transcripts derived from the chromosome 4
pseudogene predict an extra exon downstream of the 3′ end of
the pseudogene identified by the putative ancestral poly(A) tail
(Fig. 5A, b). A-Uba52-4a comprised two exons of 170 and 415
Fig. 4. Antisense transcripts of protamine 1 and protamine 2. (A) Cartoon of the Prm[1-2] antisense transcripts. The putative exons of the antisense transcripts are
shown. The exons are numbered starting from the 5′ end of the antisense transcript. The rest of the notations are the same as described in the legend to Fig. 3B. The
intergenic sequence between the Prm1gene and the Prm2 gene is ∼4.2 kb. (B) Nucleotide sequence and computer-predicted amino acid sequence of polypeptide
encoded by A-Prm[1-2]-c. A-Prm[1-2]-adoes not have exons 2 and 3; A-Prm[1-2]-b does not have exon 2. Exon–intron boundaries are indicated by←→. The SAGE
tag sequences identified in germ cell SAGE libraries are underlined. Amino acids encoded by the ORF are shown underneath the nucleotide sequence as single-letter
code. The stop codon is represented by +++. Amino acids constituting the potential casein kinase II phosphorylation sites in the putative encoded polypeptide are
underlined. Amino acids constituting potential myristoylation site are marked by asterisks.
686 W.-Y. Chan et al. / Genomics 87 (2006) 681–692bp, respectively. The first exon was complementary to a putative
exon 1830 bp downstream of the pseudogene. This exon was
spliced to an exon starting at 84 bp 5′ of the poly(A) stretch ofthe pseudogene. Splicing of the exons of A-Uba52-4a followed
the AG/GT(C) rule [18]. A-Uba52-4b, with 1048 bp, was the
largest antisense transcript derived from this pseudogene. It was
687W.-Y. Chan et al. / Genomics 87 (2006) 681–692similar to A-Uba52-4a except the second exon was larger, with
854 bp. A-Uba52-4cwas different from the other two transcripts
in that the first exon was 321 bp and was 1799 bp downstream
of the pseudogene. This exon was spliced to the second exon at
the same position as the other two antisense transcripts.
Computer-assisted translation of A-Uba52-4b revealed an
ORF of 393 bp with no recognizable protein motif.
The longest antisense transcript derived from the pseudogene
on chromosome 9, A-Uba52-9c, had 1920 bp with 298 bp in
exon 1, 161 bp in exon 2, and 1461 bp in exon 3, including a
poly(A) tail of ∼21 A's. Exon 3 overlapped with the
pseudogene of Uba52. Exon 1 was predicted to be 4060 bp
and exon 2 to be 1868 bp, downstream of the ancestral poly(A)
stretch of the pseudogene (Fig. 5A, c). A-Uba52-9b was
identical to A-Uba52-9c except that exon 3 was shorter with
only 725 bp and a poly(A) tail of ∼14 A's. A-Uba52-9a did not
have exon 2. A-Uba52-9d was identical to A-Uba52-9a except
with a LINE 1 repeat of 88 bp inserted between exons 1 and 2.
3′ extension of exon 3 of both A-Uba52-9a and A-Uba52-9d
was not successful and we sequenced only 170 bp from the 5′
end and stopped at the poly(T) stretch. Different from A-Uba52-
4b, no ORF of appreciable size could be identified in any of the
chromosome 9 antisense transcripts.
The study of the antisense transcripts of Uba52 showed that
unlike the pseudogenes, the antisense transcripts derived from
them could be composed of multiple exons and undergo
posttranscription processing. It is likely that these transcripts
have biological activities, unlike pseudogenes that are
presumed to be nonfunctional. A-Uba52-4b had an appreciable
ORF. Even though no known motif could be identified, the
potential for it to encode a novel protein could not be
precluded. The other transcripts with no significant ORF
might have regulator activities similar to that proposed for
noncoding RNAs [28]. The transcription of an antisense RNA
from a pseudogene was reported previously for neural nitric
oxide synthase [26]. In that case, the pseudogene-derived
antisense transcript was shown to regulate the synthesis of the
neural nitric oxide synthase protein. Whether the Uba52
antisense transcripts serve as regulatory RNAs is currently
under investigation.
Expression studies of antisense transcripts
The relative expression levels in mouse testis of sense and
antisense transcripts of the aforementioned 19 genes were
examined using QPCR with primer sets described in Supple-
mental Table S2. The data indicated that the expression level in
testis of the sense transcript was always significantly higher
(p b 0.001) than that of the antisense transcript. The results are
summarized in Table 1. This differential expression of the sense
and antisense transcripts in whole testis was similar to that
observed in the more differentiated germ cells such as
spermatocytes and spermatids as shown by the SAGE analysis,
with the exception of Ppic and Sh3-Stam ([12] and Table 1). In
most cases, the difference in expression levels between the
sense and the antisense transcripts as shown by QPCR was
much bigger than that revealed by PAGE analysis following RT-PCR (Supplementary Fig. S1). The discrepancy between the
QPCR and the PAGE results could be the consequence of
differences in the procedure. Since RT-PCR was done using the
one-tube procedure while QPCR involved a transfer of RT
product from one tube to another prior to performing QPCR,
any loss of RT product due to adsorption onto to the wall of the
RT reaction tube will greatly affect the result of the QPCR but
not that of the RT-PCR and PAGE. This effect will be especially
significant for low-abundance antisense transcripts. Thus the
QPCR results will not accurately reflect the relative expression
levels of the sense and antisense transcripts, particularly for the
low-abundance transcripts. Another cause of the discrepancy
could be the excessive number of PCR cycles (30 cycles)
usually performed to reveal the presence of the antisense
transcripts.
We also examined the expression of sense and antisense
transcripts of nine genes in nontesticular tissues, including
whole embryo, ovary, brain, thymus, kidney, spleen, heart,
lung, and liver, by semiquantitative orientation-specific RT-
PCR. The primers for the RT-PCR were the same as those for
studying testicular expression of the sense and the antisense
transcripts (Supplementary Table S2). Results of electropho-
resis of the RT-PCR products are shown in Fig. 6. The relative
expression levels of the sense and the antisense transcripts are
summarized in Table 2. Expression of the sense and the
antisense transcript of Pdcl2 was testis specific. The
expression of the antisense transcript of Tsg1 and Tcte3 was
also testis specific. Unlike the sense transcript, the antisense
transcript of Prm1 was ubiquitously expressed. Expression of
Prm1 and Prm2 in nontesticular tissues was reported
previously [33–35] and confirmed by nucleotide sequencing
of the TA-cloned sense and antisense amplicons (data not
shown). The sense and the antisense transcripts of Pdcl2 and
Prm2 were coexpressed in selected tissues while those of
Calm2 and Uba52 were coexpressed in all tissues examined.
On the other hand, the sense transcripts of Ppp1cc and Ppic
were ubiquitously expressed while their antisense transcripts
were found only in certain tissues.
Although the sense transcripts were often expressed at higher
levels than antisense transcripts, when the two were coex-
pressed the relative expression pattern of the sense and the
antisense transcripts varied for different genes. This was
contrary to that observed when mouse embryonic tail genes
were studied [36]. Coexpression of the sense and the antisense
transcripts in the same cell facilitates the formation of RNA
duplexes and may result in modulation of gene expression or
mRNA stability and processing [6,37,38]. Tissue-specific
expression of the antisense transcripts implies regulation of
the appropriate tissue- and cell-type expression of the sense
gene similar to that observed for Nphs1 and Dnm3 [37,39,40]. It
may also indicate regulation or activity of the antisense
transcript independent of the sense transcript as observed in
the case of FGF-2 [41].
Differential expression of sense and antisense transcripts in
different cells and tissues has been reported for a number of
imprinted genes [6,21,42]. Antisense transcripts have been
suggested to play important roles in the regulation of
688 W.-Y. Chan et al. / Genomics 87 (2006) 681–692monoallelic expression in X-chromosome inactivation and
genomic imprinting [43–45]. A number of the genes in the
present study also showed differential expression of the sense–
antisense transcripts. The sense transcript of these genes,including Prm1, Prm2, Tcte3, and Tsg1, coincidentally were
preferentially expressed in meiotic and postmeiotic cells (Tables
1 and 2). It is unknown whether these antisense transcripts have
a particular function in transcription regulation at these stages.
689W.-Y. Chan et al. / Genomics 87 (2006) 681–692The present study demonstrates the occurrence of antisense
transcription in germ cells. It is tempting to speculate that this
vigorous control of gene expression is necessary to ensure the
accuracy or to facilitate the functioning of the biological
processes occurring during spermatogenesis such as genome-
wide methylation–demethylation, genomic imprinting, mono-
allelic gene expression, etc. It suggests that mouse spermato-
genesis may be a good model for studying the regulation and
biological activities of antisense transcripts.
It has been argued that antisense transcripts arise from leaky
transcription of the noncoding strand. Even though this
possibility cannot be completely ruled out, the fact that most
of the antisense transcripts examined are polyadenylated or
processed in a manner similar to the sense transcripts suggests
that they are intentional transcripts. This is supported by the
results of a recent study comparing the genomic organization of
genes with or without antisense transcripts between human,
mouse, and pufferfish [46]. Previous studies on antisense
transcription either used a computational approach to look for
the global presence of antisense transcripts or focused on a
single gene [1–4,19–26,29,30,35,37]. Few reports document
the mechanisms by which the antisense transcripts are
generated. In the present study, similar to a recent report [47],
we used a SAGE database for the identification of antisense
transcripts. We showed that a significant percentage of
differentially expressed genes in spermatogenic germ cells are
associated with antisense transcripts. These transcripts come
from a wide spectrum of sources: processed sense mRNA, the
sense gene locus, pseudogene, two neighboring genes, and
intergenic sequence. Characterization of the cloned antisense
transcripts also showed that antisense transcripts can be
processed, alternatively spliced, capped, and polyadenylated.
There are also antisense transcripts that do not have a 5′ cap
and/or 3′ poly(A) tail. Thus the origin and structure of antisense
transcripts are very complex. Antisense transcripts have been
proposed to have functions in transcriptional and posttranscrip-
tional regulation [6,14,28,43,44,48,49]. The complex nature of
the antisense transcripts suggests that they are well suited to
provide an additional layer of vigorous regulation of gene
expression.
Materials and methods
Orientation-specific RT-PCR and QPCR
Presence of antisense transcript was confirmed by orientation-specific RT-
PCR. Total RNA from mouse tissues was purchased from Ambion (Austin,Fig. 5. Antisense transcripts of ubiquitin A 52-residue ribosomal protein fusion prod
genes and the pseudogenes, the empty and hatched boxes represent exons, while the t
the same as described in the legend to Fig. 3B. (a) Functional gene on chromosome 8.
the pseudogene on chromosome 4. The filled box represents the putative exon pre
Antisense transcripts A-Uba52-9a, -9b, -9c, and -9d of the pseudogene on chromo
downstream of the pseudogene are represented by the filled boxes. The hatched b
transcripts of Uba52. (a) A-Uba52-4b.▵ indicates the end of sequence of A-Uba52-4
⇐ indicates the 5′ end of the pseudogene. The SAGE tag sequences identified in
indicates the end of A-Uba52-9a and A-Uba52-9b. There are 14 A's following▵ in A
underlined. Exon 2 is missing in A-Uba52-9a. A-Uba52-9dis similar to A-Uba52-9a
TCCATATGCC GACTATTCAAT GCTGTTTTTA CTTTGCGGTG CAGAAATCTTX, USA). RNA integrity and concentration were checked with the
Bioanalyzer 2100 (Agilent Technologies, Germantown, MD, USA). Orienta-
tion-specific RT-PCR was performed as described previously by Shendure and
Church [14]. The One Step RT-PCR kit (Qiagen, Valencia, CA, USA) was
used according to the manufacturer's protocol with a total volume of 25 μl.
The primers were designed based on the published mRNA sequence such that
they would prime the amplification of a 120- to 230-bp sequence covering the
most 3′ sense–antisense pair. Primers were designed using Primer Express
version 2.0 (Applied Biosystems, Branchburg, NJ, USA) and specificity was
confirmed by a BLASTN search against the nonredundant and EST mouse
sets from NCBI. The sequence and location of the primers are described in
Supplemental Table S2. One microgram of total RNA was used as template in
all RT reactions. In general, 30 PCR cycles were performed for the orientation-
specific RT-PCR with the exception of cases in which the expression level of
the transcript was very high or very low. All orientation-specific RT-PCR
experiments were performed with controls in which no strand-specific primer
was added to the RT reaction [14]. Five microliters of the 25 μl product of
orientation-specific RT-PCR was analyzed by PAGE. Quantitative real-time
RT-PCR analyses were carried out as described previously [50]. Sense-specific
first-strand cDNA was synthesized as described earlier using the Qiagen One
Step RT-PCR kit. Products of the RT reaction were aliquoted for QPCR.
Primers for QPCR were the same as those used for orientation-specific RT-
PCR as described in Supplemental Table S2. QPCR was performed in
triplicate in the 7900 HTS Sequence Detection System (Applied Biosystems,
Foster City, CA, USA). Gene expression data were reported after normalizing
to 18S rRNA content. The mean cycle number and the standard deviations
were reported. Significance of expression level difference was analyzed using
Student's t test.
5′ and 3′ RACE and nucleotide sequencing
To clone the antisense transcripts, anchored PCR was performed using the
GeneRacer Kit (Invitrogen, Gaithersburg, MD, USA) according to the
manufacturer's recommendations. 5′ RACE using the GeneRacer Kit
specifically targets only 5′-capped mRNA. Reverse transcription of the ligated
mRNA to create RACE-ready first-strand cDNAwas effected using Superscript
III reverse transcriptase (Invitrogen) and orientation-specific primer. The RACE
product was amplified using nested primers and gene-specific primers before TA
cloned into the pCR 4-TOPO vector (Invitrogen) according to the manufac-
turer's protocol. The sequences of specific primers used for 5′ and 3′ RACE are
indicated in Figs. 3B, 4B, and 5B. The sequence of the cloned cDNA was
determined by cycle sequencing using BigDye Primer Cycle Sequencing Kits
(Applied Biosystems). DNA sequences were analyzed using DNASIS software
version 2.5 (MiraiBio, Alameda, CA, USA). The presence of antisense
transcripts was confirmed by repeating the RT-PCR using the most 5′ and the
most 3′ primers that were located in different exons in the antisense transcript. If
both primers were contained in the sense transcript, orientation-specific RT-PCR
was performed.
Open reading frames in the nucleotide sequence were predicted using the
NCBI ORF finder program (http://www.ncbi.nlm.nih.gov/gorf/gorf.html) and
ORF Finder (http://www.bioinformatics.org/sms/orf_find.html). Translated
amino acid sequences in the potential ORFs in FASTA format were input into
the SMART 4.0 database [51]. The output was ranked by e values. Domains
with scores that were less significant than the required threshold or overlapped
with some other source of annotation were rejected.uct 1. (A) Cartoon of the cloned Uba52 antisense transcripts. For the functional
hick line represents introns and flanking sequences. The rest of the notations are
The three exons are shown. (b) Antisense transcripts A-Uba52-4a, -4b,and -4c of
dicted by the antisense transcripts located downstream of the pseudogene. (c)
some 9. The two putative exons predicted by the antisense transcripts located
ox represents the LINE1 repeat insert. (B) Nucleotide sequence of antisense
a. There are 21 A's after this point.←→ indicates the exon–intron boundaries.
germ cell SAGE libraries are underlined. (b) A-Uba52-4c; (c) A-Uba52-9c. ▵
-Uba52-9b. The SAGE tag sequences identified in germ cell SAGE libraries are
except with the insertion of ATATATTGTT GGCAAAGATT TTTCTCCCAT
T TTAAATTC between exons 1 and 2.
Fig. 6. Polyacrylamide gel electrophoresis of the product of orientation-specific RT-PCR of nine genes in different tissues. M, size marker; S, orientation-specific RT-
PCR using primer specific for the sense transcript; As, orientation-specific RT-PCR using primer specific for the antisense strand. Control with no strand-specific
primer in the RT reaction was done in all experiments. The representative results of triplicate experiments are shown.
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Table 2
Tissue distribution of sense and antisense transcript pairs in different mouse tissues
Gene Embryo Testis Ovary Brain Thymus Kidney Spleen Heart Lung Liver
S/AS S/AS S/AS S/AS S/AS S/AS S/AS S/AS S/AS S/AS
Calm2 +++/+++ +++/+ +++/+++ +++/+ ++/+ ++/+ +++/+++ +++/+ +++/+ +++/+
Pdcl2 –/– ++/+ –/– –/– –/– –/– –/– –/– –/– –/–
Ppic ++++/+ ++++/++ ++++/+ ++/– ++++/– ++++/+ ++++/– ++++/+ ++++/– ++++/–
Ppp1cc ++++/– +++/+ ++/– ++/– ++/– ++/+ ++/+ ++/– ++/– ++/++
Prm1 –/+ +++/+++ –/+ –/++ ++/+ ++/+ ++/+ ++/+ +/+ +/+
Prm2 –/– ++++/+++ –/– –/– ++/++ –/– +/++ –/– +/++ –/–
Tcte3 –/– ++++/++ +/– +/– ++/– +/– +++/– –/– ++/– –/–
Tsg1 +/– +++/+ +/– –/– –/– +/– +/– –/– +/– +/–
Uba52 ++++/+ ++++/++++ ++++/+ ++++/+ ++++/+++ ++++/+ ++++/++++ ++++/+ ++++/++ +++/+
S, sense transcript expression; AS, antisense transcript expression; + indicates the presence of a band and the number of +'s represents the visual intensity of the
band; – indicates the absence of a band.
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